CD8A and cancer: The T cell receptor (TCR) and co-receptor of CD8 recognize the MHC1 complex, and the T cell interaction begins. The polymorphisms of TAP genes may change the structure and function of the complex and induce profound effects on immune surveillance and cancer susceptibility [10].